CV Shariat_AKH - Vienna OMI

More documents

Recommendations

Info

• Invited Lecturer, 20 th Association Marocaine d’Urologie (AMU) Annual Meeting 4/4-7/20123ème congrèsand 20 th Congres Francophone D’ Urologie (FASULF) 2012, Marrakech, Morocco.Traitement intravésical du cancer de vessie: thérapie de première ligne et algorithme de prise enchargeCancer du rein de petite taille: place de la radiofréquence, de la cryothérapie• Invited Lecturer, Department of Surgery, Maimonides Medical Center, 4/16/2012Brooklyn, NY, USALymphadenectomy for prostate cancer: extended, standard, limited, or not at all• Invited Lecturer, III Simposio Internacional de Cancer Urologico, 4/20-21/2012Sao Paulo, SP, BrazilIntravesical therapy for T1high grade (T1G3)Role of urinary and tissue markers in bladder cancer detection and prognosisBladder cancer in elderly: what is different?Prognostic markers in upper tract urothelial carcinoma: what have we learned in the last 5 yearsUpper tract urothelial carcinoma: when is conservative therapy indicated and safe?Case Discussion: Bladder CancerRole of ablative therapyCase Discussion: Kidney CancerThe biologic and clinical importance of teratomaActive surveillance: reasonable or risky?Case Discussion: Prostate Cancer• Invited Lecturer, Department of Urology, Albert Einstein College of Medicine, 5/7/2012Montefiore Medical Center Center, Bronx, NY, USAUpper tract urothelial carcinoma: what have we learned in the last 5 years?• Invited Lecturer, Clinical Medicine, Weill Cornell Medical Associates-East Side 5/17/2012New York, NY, USAProstate cancer: a thinking man’s approach• Course Director and Lecturer, American Urological Association Association 5/22/2012Annual Meeting, Atlanata, GA, USA051IC: Contemporary Concepts and Controversies in the Diagnosis and Management of UpperTract Urothelial Carcinoma (UTUC)• Invited Lecturer, Sol and Margaret Berger Department of Urology, Beth Israel Medical 6/14/2012Center, New York, NY, USAManagement of upper tract urothelial carcinoma• Course Director and Lecturer, EAU/Weill Cornell Seminar in“ESU Master Class7/9-14/2012in Urology”, Salzburg, AUTNon-muscle invasive bladder cancer: diagnosis & overviewChemotherapy for bladder cancerWorkshop: why & how to publish in European UrologyWorkshops: fellows’ case presentations• Invited Lecturer, Australian and New Zealand Urogenital and Prostate Clinical 7/16-17/2012Trials Group (ANZUP) Annual Scientific Meeting, Sydney, Australia.State of the art in the diagnosis and treatment of upper tract urothelial carcinomaOptimal management of bladder cancer- integrating surgery and systemic therapyRole of surgery in the treatment of high-risk non-metastatic prostate cancerGenitourinary carcinoma clinical trial concept development• Invited Lecturer, Weill Cornell Medical College & Eli Lilly & Co 11/7/20122 nd Men's Health Symposium: From Academic Research to New Drug Developments,Weill Cornell Medical College, New York, NY, USAwww.vienna-omi.at 28.08.2013
Bladder cancer: opportunities for innovation• Invited Lecturer, Fortbildungstagung der Österreichischen Gesellschaft 11/10/2012für Urologie und Andrologie. 9-10 November 2012. Linz, AustriaRadikale Prostatektomie- state of the art surgery13 Tipps für eine erfolgreiche Karriere in der urologischen Forschung• Invited Lecturer, Society of Basic Urologic Research Annual Symposium, 11/17/2012November 15-8, 2012. Miami, FL, USABiomolecular predictors of urothelial cancer behavior and treatment outcomes• Panelist, Summit on Upper Tract Urothelial Carcinoma, Society of Urologic 11/28/2012Oncology Annual Meeting, Bethesda, MD, USAAchieving consensus on clinical risk stratificationManagement of localized disease• Invited Lecturer, 19 th St Lawrence Urological Group, McGill University 1/25-27, 2013Health Centre, Montreal, Quebec, CanadaMy 15 tips for a successful career in academic urologyHow to choose a fellowship – a primer for residentsConcepts and controversies in the management of upper tract urothelial carcinomaIntegration surgery and systemic therapy for invasive bladder cancer• Invited Lecturer, Joint session of the European association of urology(EAU) and 3/15/2013the Maghreb Union countries. 28 th Annual EAU Congress. March 2013,Milan, Italy.Management of non invasive bladder tumors• Invited Lecturer, Plenary session 2 – Debate: How much surgery for upper tract3/17/2013urothelial cancer? 28 th Annual EAU Congress. March 2013, Milan, Italy.Nephroureterectomy or partial ureterectomy?• Course Director and Lecturer, 28 th Annual EAU Congress. March 2013, Milan, Italy.3/18/2013 ESU course 31 Current concepts and controversy in the diagnosis andmanagementof upper tract urothelial carcinoma (UTUC)Prognostic and opredictive factors, pathiologyTreatment of localized high risk (invasive) and metastatic cancerInvited Lecturer, National Urology Residents Preceptorship Program (NURPP), 5/5/ 2013AUA 2013 Annual Meeting, May 4-8, San Diego, CAFellowships- a primer for residentsInvited Lecturer, American Society for Men's Health, AUA 2013 Annual Meeting, 5/6/2013May 4-8, San Diego, CA, USALocalized Prostate Cancer: Active Surveillance versus Active Treatment?Chair and lecturer, Association of American-Iranian Urologists (AAIU), 5/6/2013AUA 2013 Annual Meeting, May 4-8, San Diego, CA, USAT1 bladder cancer: conservative therapy is the initial way to go• Course director and lecturer, American Urological Association Association 5/7/2013Annual Meeting 2013, San Diego, CA, USAwww.vienna-omi.at 28.08.2013
Page 1 and 2: SHAHROKH F. SHARIAT, MDProfessor an
Page 3 and 4: E D U C A T I O N & M E D I C A L T
Page 5 and 6: • Glaxo SmithKline Scholar Award,
Page 7 and 8: May 29-June 3, 2010. J.Urol 183(4):
Page 9 and 10: • Leading Physician of the World
Page 11 and 12: Weill Cornell Medical Center, Princ
Page 13 and 14: Inventor: Shahrokh ShariatThe prese
Page 15 and 16: • Chair of Sessions - The Inaugur
Page 17 and 18: • Guest Editor of special issue o
Page 19 and 20: • Visiting Professor, Division of
Page 21: Ablative therapy for small renal co
Page 25 and 26: 7. Merseburger AS, Herrmann TR, Sha
Page 27 and 28: 36. May M, Ficarra V, Shariat SF, Z
Page 29 and 30: Results from of a Large Multicenter
Page 31 and 32: trends and disparities in the use o
Page 33 and 34: 112. Abdollah F, Sun M, Thuret R, J
Page 35 and 36: 139. Fajkovic H, Cha EK, Jeldres C,
Page 37 and 38: RK, Margulis V, Shariat SF: Tissue-
Page 39 and 40: 21869907190. Abdollah F, Sun M, Jel
Page 41 and 42: Montorsi F, Karakiewicz PI: The imp
Page 43 and 44: Fradet Y, Shariat SF. Prognostic ri
Page 45 and 46: 271. Shariat SF, Lotan Y, Vickers A
Page 47 and 48: 298. Shariat SF, Kattan MW, Vickers
Page 49 and 50: 324. Capitanio U, Isbarn H, Shariat
Page 51 and 52: 349. Margulis V, Shariat SF, Matin
Page 53 and 54: 378. Karakiewicz PI, Bhojani N, Cap
Page 55 and 56: 410. Shariat SF, Lamb DJ, Iyengar R
Page 57 and 58: 442. Chun FK, Briganti A, Gallina A
Page 59 and 60: cystectomy for primary nontransitio
Page 61 and 62: Slawin KM. Salvage radiotherapy for
Page 63 and 64: 535. Shariat SF, Desai S, Song W, K
Page 65 and 66: 21. SunM., Abdollah F., Schmitges J
Page 67 and 68: progression after radical prostatec
Page 69 and 70: Y., Karakiewicz P.: Assessement of
Page 71 and 72: 50. Shariat S., Karakiewicz P., Fra
Page 73 and 74:
predictions in patients with adreno
Page 75 and 76:
Schoenberg, G. E. Amiel, S. P. Lern
Page 77 and 78:
113. Claudio Jeldres, Maxime Crepel
Page 79 and 80:
(volume 183 issue 4 Page e227)134.
Page 81 and 82:
156. Ramy Youssef, Shahrokh Shariat
Page 83 and 84:
Localized .Sunday, May 15, 2011 Ame
Page 85 and 86:
Health Conference. 2-5 October 2011
Page 87 and 88:
urothelial carcinoma. Poster #155.
Page 89 and 90:
supplementation on the prevention o
Page 91 and 92:
for metastatic renal cell carcinoma
Page 93 and 94:
muscle-invasive urothelial carcinom
Page 95 and 96:
Shahrokh Shariat Prediction of intr
Page 97 and 98:
Terrone; Derya Tilki; Daniel Vergho
Page 99 and 100:
P.I.: Drs. Shahrokh Shariat and Dou
show all

CV Shariat_AKH - Vienna OMI

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?